Journal Information
Vol. 38. Issue 3.
Pages 231 (March 2019)
Share
Share
Download PDF
More article options
Vol. 38. Issue 3.
Pages 231 (March 2019)
Recommended Article of the Month
Open Access
Brief Comment Video to the Recommended Article of the Month
Breve Comentário Vídeo ao Artigo Recomendado do Mês
Visits
2521
This item has received

Under a Creative Commons license
Article information
Full Text
Download PDF
Statistics
Figures (1)
Full Text

SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials

Thomas A. Zelniker, Stephan D. Wiviott, Itamar Raz, Kyungah Im, Erica L. Goodrich, Marc P. Bonaca, Ofri Mosenzon, Eri T. Kato, Avivit Cahn, Remo H. M. Furtado, Deepak L. Bahatt, Lawrence A. Leiter, Darren K. McGuire, John P. H. Wilding, Marc S. Sabatine (in Lancet 2019;393:31-39)

Entrevistada: Cristina Gavina

Entrevistador: Ricardo Fontes-Carvalho

Link: https://www.youtube.com/watch?v=IeUqwbhKVm0&list=PL-uOq5lzrAwa8yYWWoJ9RQphZyY3DVyEx∈dex=12

Conflicts of interest

The authors have no conflicts of interest to declare.

Please cite this article as: en. Brief Comment Video to the Recommended Article of the Month. Rev Port Cardiol. 2019;38:231.

Download PDF
Idiomas
Revista Portuguesa de Cardiologia (English edition)
Article options
Tools
en pt

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

By checking that you are a health professional, you are stating that you are aware and accept that the Portuguese Journal of Cardiology (RPC) is the Data Controller that processes the personal information of users of its website, with its registered office at Campo Grande, n.º 28, 13.º, 1700-093 Lisbon, telephone 217 970 685 and 217 817 630, fax 217 931 095, and email revista@spc.pt. I declare for all purposes that the information provided herein is accurate and correct.